FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2938726064> ?p ?o ?g. }

• W2938726064 endingPage "8470" @default.
• W2938726064 startingPage "8463" @default.
• W2938726064 abstract "There are adaptive T-cell and antibody autoimmune responses to myelin-derived peptides in multiple sclerosis (MS) and to aquaporin-4 (AQP4) in neuromyelitis optica spectrum disorders (NMOSDs). Strategies aimed at antigen-specific tolerance to these autoantigens are thus indicated for these diseases. One approach involves induction of tolerance with engineered dendritic cells (tolDCs) loaded with specific antigens. We conducted an in-human phase 1b clinical trial testing increasing concentrations of autologous tolDCs loaded with peptides from various myelin proteins and from AQP4. We tested this approach in 12 patients, 8 with MS and 4 with NMOSD. The primary end point was the safety and tolerability, while secondary end points were clinical outcomes (relapses and disability), imaging (MRI and optical coherence tomography), and immunological responses. Therapy with tolDCs was well tolerated, without serious adverse events and with no therapy-related reactions. Patients remained stable clinically in terms of relapse, disability, and in various measurements using imaging. We observed a significant increase in the production of IL-10 levels in PBMCs stimulated with the peptides as well as an increase in the frequency of a regulatory T cell, known as Tr1, by week 12 of follow-up. In this phase 1b trial, we concluded that the i.v. administration of peptide-loaded dendritic cells is safe and feasible. Elicitation of specific IL-10 production by peptide-specific T cells in MS and NMOSD patients indicates that a key element in antigen specific tolerance is activated with this approach. The results warrant further clinical testing in larger trials." @default.
• W2938726064 created "2019-04-25" @default.
• W2938726064 creator A5010243880 @default.
• W2938726064 creator A5012275404 @default.
• W2938726064 creator A5014149554 @default.
• W2938726064 creator A5016235381 @default.
• W2938726064 creator A5018652145 @default.
• W2938726064 creator A5018737283 @default.
• W2938726064 creator A5020456692 @default.
• W2938726064 creator A5021775232 @default.
• W2938726064 creator A5030692837 @default.
• W2938726064 creator A5038784094 @default.
• W2938726064 creator A5043687800 @default.
• W2938726064 creator A5047518173 @default.
• W2938726064 creator A5051118910 @default.
• W2938726064 creator A5051446807 @default.
• W2938726064 creator A5052991027 @default.
• W2938726064 creator A5056046035 @default.
• W2938726064 creator A5063133578 @default.
• W2938726064 creator A5063848310 @default.
• W2938726064 creator A5072712902 @default.
• W2938726064 creator A5076786150 @default.
• W2938726064 creator A5078291719 @default.
• W2938726064 creator A5080119173 @default.
• W2938726064 creator A5083602174 @default.
• W2938726064 creator A5087062348 @default.
• W2938726064 creator A5088301395 @default.
• W2938726064 date "2019-04-08" @default.
• W2938726064 modified "2023-10-16" @default.
• W2938726064 title "Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial" @default.
• W2938726064 cites W1579832371 @default.
• W2938726064 cites W1785561849 @default.
• W2938726064 cites W1833759296 @default.
• W2938726064 cites W1966703115 @default.
• W2938726064 cites W1976696463 @default.
• W2938726064 cites W1979990420 @default.
• W2938726064 cites W1991290108 @default.
• W2938726064 cites W2037377025 @default.
• W2938726064 cites W2043149094 @default.
• W2938726064 cites W2064869298 @default.
• W2938726064 cites W2073133083 @default.
• W2938726064 cites W2086547450 @default.
• W2938726064 cites W2100892626 @default.
• W2938726064 cites W2102960796 @default.
• W2938726064 cites W2104464991 @default.
• W2938726064 cites W2105211854 @default.
• W2938726064 cites W2112165124 @default.
• W2938726064 cites W2113504797 @default.
• W2938726064 cites W2116741625 @default.
• W2938726064 cites W2117477752 @default.
• W2938726064 cites W2122532904 @default.
• W2938726064 cites W2122545833 @default.
• W2938726064 cites W2125323202 @default.
• W2938726064 cites W2128597204 @default.
• W2938726064 cites W2129229339 @default.
• W2938726064 cites W2140902526 @default.
• W2938726064 cites W2142577589 @default.
• W2938726064 cites W2150297240 @default.
• W2938726064 cites W2150378783 @default.
• W2938726064 cites W2159463165 @default.
• W2938726064 cites W2161354474 @default.
• W2938726064 cites W2166722740 @default.
• W2938726064 cites W2180435160 @default.
• W2938726064 cites W2279983710 @default.
• W2938726064 cites W2332451323 @default.
• W2938726064 cites W2473015308 @default.
• W2938726064 cites W2496406988 @default.
• W2938726064 cites W2509787928 @default.
• W2938726064 cites W2518169008 @default.
• W2938726064 cites W2526011178 @default.
• W2938726064 cites W2559862761 @default.
• W2938726064 cites W2763088306 @default.
• W2938726064 cites W2791703022 @default.
• W2938726064 cites W2799373129 @default.
• W2938726064 cites W2801270536 @default.
• W2938726064 cites W2806773774 @default.
• W2938726064 cites W4233752323 @default.
• W2938726064 cites W4292806894 @default.
• W2938726064 doi "https://doi.org/10.1073/pnas.1820039116" @default.
• W2938726064 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6486735" @default.
• W2938726064 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30962374" @default.
• W2938726064 hasPublicationYear "2019" @default.
• W2938726064 type Work @default.
• W2938726064 sameAs 2938726064 @default.
• W2938726064 citedByCount "97" @default.
• W2938726064 countsByYear W29387260642019 @default.
• W2938726064 countsByYear W29387260642020 @default.
• W2938726064 countsByYear W29387260642021 @default.
• W2938726064 countsByYear W29387260642022 @default.
• W2938726064 countsByYear W29387260642023 @default.
• W2938726064 crossrefType "journal-article" @default.
• W2938726064 hasAuthorship W2938726064A5010243880 @default.
• W2938726064 hasAuthorship W2938726064A5012275404 @default.
• W2938726064 hasAuthorship W2938726064A5014149554 @default.
• W2938726064 hasAuthorship W2938726064A5016235381 @default.
• W2938726064 hasAuthorship W2938726064A5018652145 @default.
• W2938726064 hasAuthorship W2938726064A5018737283 @default.
• W2938726064 hasAuthorship W2938726064A5020456692 @default.

• next